An MHRA accredited Manufacturing Facility based in Maidenhead, UK.
Fundamentally an ethical and responsible pharmaceutical company, Noumed maintains a quality-focused culture to ensure the highest priority is placed on the safety, efficacy and reliability of products, patient safety, and the quality of data supporting regulatory submissions. Noumed is committed to maintaining a quality culture with appropriate systems and processes in place to drive quality-focused behaviours.
Quality
Noumed’s business is carried out in compliance with applicable quality regulations, codes and standards; the Quality Policy is implemented through a software supported Quality Management System. Personnel performance is monitored and regularly reviewed to ensure the standards of conduct meet high expectations of quality for the patients.
Regulatory Affairs
A team dedicated to of regulatory affairs ensure Noumed’s medicine approvals are managed efficiently by preparing CMCs, Pre-clinical, Clinical, Product Information (PI), Labelling and Patient information. The regulatory team has undertaken regulatory filings using eCTD formats in regulated markets. The team also has expertise in post-approval and product lifecycle management.
Pharmacovigilance
Noumed has outsourced pharmacovigilance activities to a third party. There is a dedicated QPPV to comply with all requirement of pharmacovigilance.
An MHRA accredited manufacturing facility manufactures multiple dosage forms and flexible batch sizes
Quality Control is fitted with high-spec analytical and testing equipment to support manufacturing and development
The fully equipped warehouse has provisions to store materials requiring cold storage conditions. It also has a dedicated area to store controlled substances
The focus on adhering to GMP guidelines and ensuring compliance to regulations, enables us to meet quality, efficacy and safety requirements. Through pharmacovigilance, product performance is regularly monitored to ensure patient safety
Noumed has a network of CMOs in various geographies to manufacture diverse dosage forms in addition to what can be manufactured in-house